TNYA
Tenaya Therapeutics Inc.
Company Overview
| Mkt Cap | $229.80M | Price | $1.44 |
| Volume | 5.16M | Change | +14.29% |
| P/E Ratio | -2.1 | Open | $1.24 |
| Revenue | -- | Prev Close | $1.26 |
| Net Income | $-111.1M | 52W Range | $0.36 - $4.01 |
| Div Yield | N/A | Target | $10.14 |
| Overall | 49 | Value | 60 |
| Quality | 26 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyTenaya Therapeutics Inc. (TNYA) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $1.44 with a market capitalization of $229.80 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TNYA with a volume of 5.16 million shares. The stock opened down 1.59% from yesterday's close of $1.26. Current analyst estimates project earnings of $-0.68 per share for this year, with next year targeting $-0.56.
TNYA demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for TNYA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 604.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:47 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNYA | $1.44 | +14.3% | 5.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tenaya Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW